| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.094 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |